OCGN - Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit | Benzinga
MALVERN, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen will present at the Abu Dhabi Family Office (ADFO) Summit being held February 29—March 1, 2024 at the Saadiyat Rotana Resort and Villas in Abu Dhabi, United Arab Emirates.
"I'm honored to be an invited speaker among the prestigious gathering at the ADFO Summit," said Dr. Musunuri. "This is an excellent opportunity to share more about the potential of Ocugen's novel modifier gene therapy platform in an area of the world where there's a high incidence of blindness diseases. I'm confident that this event will help raise awareness while also making important introductions for Ocugen."
Details of the presentation are as follows:
Interactive Panel 7—How family offices are drawn towards longevity, healthcare, life sciences and wellness as they come to terms with family challenges and the impact of modern lifestyle
Date: Friday, March 1, 2024
Presentation Time: 3:05-3:45 p.m. GST
Location: Saadiyat Rotana Resort and Villas in Abu ...